Methodological considerations on the meta-analysis of doxycycline versus azithromycin for Chlamydia trachomatis in cis-men

Abstract

Get full access to this article

View all access options for this article.

References

Boujemaa

Suri

Kaur

. Efficacy and safety of doxycycline versus azithromycin for the treatment of Chlamydia trachomatis in cis-men: a systematic review and meta-analysis. Int J STD AIDS 2026: 9564624261435919. https://doi.org/10.1177/09564624261435919

Page

McKenzie

Bossuyt

, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. https://doi.org/10.1136/bmj.n71

Furuya-Kanamori

, et al. Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study. BMJ 2022; 377: e069155. https://doi.org/10.1136/bmj-2021-069155

Afonso

Ramirez-Campillo

Clemente

, et al. The perils of misinterpreting and misusing “publication bias” in meta-analyses: an education review on funnel plot-based methods. Sports Med 2024; 54: 257–269. https://doi.org/10.1007/s40279-023-01927-9

Geissbühler

Vinceti

Egger

, et al. Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: a meta-epidemiological study. BMC Med Res Methodol 2021; 21: 123. https://doi.org/10.1186/s12874-021-01310-0